News

Upcoming Financial Reporting Schedule for Harju Elekter Group

Upcoming Financial Reporting Schedule for Harju Elekter Group

Key Financial Reporting Dates for Harju Elekter Group

Harju Elekter Group is set to release its financial results for the upcoming year in 2026. This schedule is important for investors and stakeholders who track the company’s performance. Here’s what you can expect:

Quarterly and Annual Reports

The following interim results will be published throughout the year:

  • 2025 interim report 4Q results: 19.02.2026
  • 2026 interim report 1Q results: 23.04.2026
  • 2026 interim report 2Q results: 23.07.2026
  • 2026 interim report 3Q results: 22.10.2026

These dates are crucial for understanding the company’s ongoing financial health, allowing investors to analyze performance and trends effectively.

Annual General Meeting Schedule

Moreover, investors should mark their calendars for the annual general meeting of shareholders, which is scheduled for the end of April 2026. This meeting will be an opportunity for shareholders to discuss the company’s future direction and significant developments. Active participation helps shareholders voice their opinions and contribute to the company’s strategic decisions.

Leadership Insights

Under the guidance of Tiit Atso, the Chairman of the Management Board, Harju Elekter Group continues to focus on enhancing shareholder value while navigating through various challenges in the industry. With a commitment to transparency, the company provides timely updates on their financial health, which is essential for maintaining investor trust and confidence.

For inquiries, you can reach out to Tiit Atso at +372 674 7400. This direct communication channel emphasizes the company’s approachability and willingness to engage with its stakeholders.

Frequently Asked Questions

What are the key financial dates for Harju Elekter Group in 2026?

The key financial dates include quarterly results on 19.02, 23.04, 23.07, and 22.10 of 2026.

When is the annual general meeting scheduled?

The annual general meeting of shareholders is set for 30 April 2026.

Who is leading Harju Elekter Group?

Tiit Atso is the Chairman of the Management Board, guiding the company’s strategic direction.

How does Harju Elekter communicate with shareholders?

The company encourages direct communication, with Tiit Atso available at +372 674 7400 for inquiries.

Why are these financial reports important?

These reports help investors assess the financial performance and health of Harju Elekter Group, influencing investment decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics

Updated Category News Views 260

Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...

Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth

Updated Category Stocks Views 404

Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...

Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions

Updated Category News Views 259

Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...

Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments

Updated Category News Views 169

Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...

Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88

Updated Category News Views 74

Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...

Continue Reading